Stem cell treatment for lung blood pressure in premature babies
Part of Lungs & breathing, Women’s health & pregnancy clinical trials.
This trial tests an experimental stem cell medicine (called PNEUMOSTEM) given to very premature babies who have early signs of high blood pressure in the lungs (pulmonary hypertension). The goal is to see if it can improve breathing and overall outcomes for these fragile infants.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be born very early (28 weeks or less) or weigh less than 1,250 grams at birth.
- Your baby must need a breathing tube and machine (ventilator) to help them breathe.
- Your baby must have signs of high blood pressure in the lungs (pulmonary hypertension) within the first 2 weeks after birth, confirmed by a heart ultrasound or because they needed nitric oxide gas.
- Your baby must not have certain serious heart defects, lung problems, severe infections, or major birth defects.
- The study team will review your baby's health and decide if they can join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving stem cells to very premature babies can help prevent bronchopulmonary dysplasia, a lung condition that often affects babies born before 28 weeks. The stem cells are given through an IV, and the study compares them to a placebo to see if they improve lung health.
This Phase 1 trial tests whether giving stem cells into a breathing tube is safe and may help prevent bronchopulmonary dysplasia (BPD), a serious lung condition in very premature infants. It focuses on babies soon after birth who already need breathing support and are at risk.
This trial tests whether umbilical cord stem cells can help premature babies with severe bronchopulmonary dysplasia (a chronic lung disease) who still need a breathing tube after standard hormone treatment. The goal is to see if it is safe and improves their lung condition.
This trial tests if stem cells can help premature babies with severe lung disease (bronchopulmonary dysplasia). It is for very small, early-born babies who still need a breathing machine between 5 and 14 days after birth.
This study tests whether changing oxygen targets in preterm infants with high blood pressure in the lungs (pulmonary hypertension) helps their heart and lungs work better. It may help doctors find the best oxygen levels for these babies.
This study tests whether a special cell therapy (MSC-EVs) given to extremely premature babies can help prevent a serious lung disease called bronchopulmonary dysplasia (BPD). The treatment is given while the baby is still on a breathing machine.
Hear when a new Pulmonary Arterial Hypertension (PAH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.